Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill shows promise for social anxiety in early trial

NCT ID NCT06693609

First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 19 times

Summary

This study tested a new oral drug called EMP-01 in 70 adults with social anxiety disorder. The goal was to see if it is safe and if it can help reduce anxiety symptoms compared to a placebo. The trial was completed and focused on short-term treatment effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOCIAL ANXIETY DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • MAC Clinical Research - Greater Manchester

    Manchester, Greater Manchester, M13 9NQ, United Kingdom

  • MAC Clinical Research - Lancashire

    Blackpool, Lancashire, FY2 0JH, United Kingdom

  • MAC Clinical Research - Merseyside

    Liverpool, Merseyside, L34 1BH, United Kingdom

  • MAC Clinical Research - South Staffordshire

    Bridgetown, Cannock, Staffordshire, S75 3DL, United Kingdom

  • MAC Clinical Research - South Yorkshire

    Tankersley, South Yorkshire, S75 3DL, United Kingdom

  • MAC Clinical Research - Teesside

    Thornaby, Stockton-on-Tees, TS17 6EW, United Kingdom

  • MAC Clinical Research Centre, West Yorkshire

    Leeds, LS10 1DU, United Kingdom

Conditions

Explore the condition pages connected to this study.